Immunotherapy in genitourinary malignancies. – UroToday
|
Immunotherapy in genitourinary malignancies.
UroToday Secondly, a small but substantial number of patients with metastatic disease are cured by immunotherapy or achieve durable responses lasting for a number of years. In this article, we review the FDA-approved immunotherapy agents in the field of … |
